Trials / Completed
CompletedNCT00954057
Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)
A Single-masked, Placebo Controlled, Multi-center Pilot Study to Determine the Safety and Efficacy of Orbital Injections of a Fixed Dose of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Neothetics, Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot study to determine the safety and efficacy of orbital injections of LIPO-102.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LIPO-102 | intraorbital injection |
| DRUG | Placebo | intraorbital injection |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2009-08-06
- Last updated
- 2015-03-26
Locations
5 sites across 2 countries: Australia, New Zealand
Source: ClinicalTrials.gov record NCT00954057. Inclusion in this directory is not an endorsement.